Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Garfall, AL"'
Autor:
Krishnan, AY, Garfall, AL, Mateos, MV, van de Donk, NWCJ, Nahi, H, San-Miguel, JF, Oriol, A, Rosinol, L, Chari, A, Bhutani, M, Karlin, L, Benboubker, L, Pei, LX, Verona, R, Girgis, S, Stephenson, T, Goldberg, JD, Banerjee, A, Usmani, SZ
Publikováno v:
Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8d76099a4eecef2586ede6c45f26c967
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2031
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2031
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S343-S343
Autor:
Mateos, M, Hari, P, Bahlis, N, Chari, A, van de Donk, NWCJ, Dholaria, B, Garfall, AL, Goldschmidt, H, Kortüm, KM, Krishnan, A, Martin, T, Morillo, D, Oriol, A, Reece, D, Rodriguez, C, Rodríguez‐Otero, P, San‐Miguel, JF, Usmani, SZ, Verona, R, Lin, SXW
Publikováno v:
HemaSphere; Apr2022 Supplement 1, Vol. 6, p9-9, 1p
Autor:
van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl., Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Costa LJ; University of Alabama at Birmingham, Birmingham, AL, USA., Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Perrot A; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Garfall AL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Thaman P; Janssen Research & Development, Bridgewater, NJ, USA., Qi K; Janssen Research & Development, Titusville, NJ, USA., Uhlar C; Janssen Research & Development, Spring House, PA, USA., Chastain K; Janssen Research & Development, Raritan, NJ, USA., Doyle M; Janssen Sciences Ireland, Dublin, Ireland., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 21; Vol. 14 (1), pp. 186. Date of Electronic Publication: 2024 Oct 21.
Autor:
van de Donk NWCJ; Amsterdam UMC Location VUmc, Amsterdam, Netherlands., Rasche L; University Hospital Würzburg, Würzburg, Germany., Sidana S; Stanford University, Stanford, california, United States., Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Garfall AL; University of Pennsylvania, Philadelphia, United States.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Elise.Chong@pennmedicine.upenn.edu., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Therwhanger D; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Gerson JN; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Fraietta JA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Weber E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Stefano N; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Porter DL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Frey NV; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Garfall AL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jul; Vol. 30 (7), pp. 726.e1-726.e8. Date of Electronic Publication: 2024 Mar 16.
Autor:
Hasanali ZS; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Garfall AL; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Burzenski L; Jackson Laboratories, Bar Harbor, Maine, USA., Shultz LD; Jackson Laboratories, Bar Harbor, Maine, USA., Tang Y; Center for Cellular Immunotherapies., Kadu S; Center for Cellular Immunotherapies., Sheppard NC; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine, and., Liu W; Center for Cellular Immunotherapies., Dopkin D; Stem Cell and Xenograft Core Facility, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Vogl DT; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Cohen AD; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Waxman AJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Susanibar-Adaniya SP; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Carroll M; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Stem Cell and Xenograft Core Facility, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Stadtmauer EA; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Allman D; Department of Pathology and Laboratory Medicine, and.
Publikováno v:
JCI insight [JCI Insight] 2024 May 07; Vol. 9 (10). Date of Electronic Publication: 2024 May 07.
Autor:
Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Patel V; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Fardella E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Gabrielli G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Carter J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Pajarillo R; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., White G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Weber E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Napier E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Porter DL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Garfall AL; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Apr 22; Vol. 17 (1), pp. 19. Date of Electronic Publication: 2024 Apr 22.
Autor:
Ghilardi G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Williamson S; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Pajarillo R; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Paruzzo L; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chen L; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Grady C; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Doucette A; Division of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia., Nemecek E; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Gabrielli G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Barta SK; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Svoboda J; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chong EA; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Yelton R; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Nasta SD; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Landsburg DJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ugwuanyi O; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chen AI; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Schachter L; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., White G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ballard HJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Weber E; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Curley C; Division of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia., Porter DL; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia., Garfall AL; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia., Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Guerra CE; Division of General Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia., Maziarz RT; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Schuster SJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ruella M; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
Publikováno v:
NEJM evidence [NEJM Evid] 2024 Apr; Vol. 3 (4), pp. EVIDoa2300213. Date of Electronic Publication: 2024 Mar 26.
Autor:
Hasanali ZS; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA., Razzo B; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA., Susanibar-Adaniya SP; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA., Garfall AL; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA., Stadtmauer EA; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA., Cohen AD; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA. Electronic address: Adam.Cohen@pennmedicine.upenn.edu.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2024 Apr; Vol. 38 (2), pp. 383-406. Date of Electronic Publication: 2023 Dec 28.